RIX-4414Systemic rotavirus infection: case report

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-018-41040-9
中图分类号
学科分类号
摘要
引用
收藏
页码:181 / 181
相关论文
共 50 条
  • [31] Pharmacoeconomic Spotlight on Rotavirus Vaccine RIX4414 (Rotarix (TM)) in Developed Countries
    Plosker, Greg L.
    DRUGS IN R&D, 2012, 12 (04) : 239 - 244
  • [32] Efficacy, Immunogenicity and Safety of a Human Rotavirus Vaccine RIX4414 in Singaporean Infants
    Phua, Kong Boo
    Lim, Fong Seng
    Quak, Seng Hock
    Lee, Bee Wah
    Teoh, Yee Leong
    Suryakiran, Pemmaraju V.
    Han, Htay Htay
    Bock, Hans L.
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2016, 45 (02) : 44 - 50
  • [33] Cost-effectiveness analysis of vaccination against rotavirus with RIX4414 in France
    Baudouin Standaert
    Nathalie Parez
    Bertrand Tehard
    Xavier Colin
    Bruno Detournay
    Applied Health Economics and Health Policy, 2008, 6 (4) : 199 - 216
  • [34] Rotavirus Vaccine RIX4414 (Rotarix™)A Viewpoint by David I. Bernstein
    David I. Bernstein
    Pediatric Drugs, 2006, 8 (6) : 396 - 396
  • [35] Cost-Effectiveness Analysis of Vaccination against Rotavirus with RIX4414 in France
    Standaert, Baudouin
    Parez, Nathalie
    Tehard, Bertrand
    Colin, Xavier
    Detournay, Bruno
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2008, 6 (04) : 199 - 216
  • [36] THE HUMAN ROTAVIRUS VACCINE RIX4414 IN INFANTS: AN INTEGRATED SAFETY SUMMARY (ISS)
    Suryakiran, P. V.
    Vinals, C.
    Vanfraechem, K.
    Han, H. H.
    Guerra, Y.
    Buyse, H.
    ACTA PAEDIATRICA, 2011, 100 : 56 - 57
  • [37] COST-EFFECTIVENESS ANALYSIS OF VACCINATION AGAINST ROTAVIRUS WITH RIX4414 IN FRANCE
    Standaert, B. A.
    Parez, N.
    Tehard, B.
    Colin, X.
    Detournay, B.
    VALUE IN HEALTH, 2008, 11 (06) : A435 - A435
  • [39] Efficacy of RIX4414 live attenuated human rotavirus vaccine in Finnish infants
    Vesikari, T
    Karvonen, A
    Puustinen, L
    Zeng, SQ
    Szakal, ED
    Delem, A
    De Vos, B
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (10) : 937 - 943